Ernexa Therapeutics Inc. ERNA
NASDAQ · United States · Health Technology
$3.10-0.10 (-3.13%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -3.30 | -3.30 | 0.0% | +2.7%$4.10→$4.21 |
| Q1 2026 | 2026-05-11 | -6.95 | — | — | +59.5%$7.53→$12.01 |
| Q4 2025 | 2026-03-13 | -0.25 | — | — | -3.2%$7.75→$7.50 |
| Q3 2025 | 2025-11-07 | -3.75 | — | — | -1.2%$42.25→$41.75 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.